Home Contact
Corporate Governance Partners
About Us
Our Team
Partners
Sequencing Service
Presentations
News Feeds
Cancer Info
Links
LOGIN NAME:

PASSWORD:
Login
Diagnomics

Diagnomics is an early stage Next Generation Sequencing (NGS) and genomics company based in San Diego. It's seed capital investor is Genautica.

The company's founders are a team of eminently qualified scientists who were also the founders of PGI Korea - an NGS non-profit entity that sequenced the 1st woman, the 1st Korean and 2nd Asian. PGI also has an exclusive collaboration agreement with BGI Shenzhen, China - the leading genome center in the world.

Diagnomics' objective is to set-up NGS genome centers, first in San Diego, CA then worldwide.